vectorvest values starpharma at under 20 cents, page-3

Not sure where you get your timeframe from - a number of factors, trials and work to date including BV suggest "fast track" will be what the term suggests.

Excerpt from a recent interview:

DR JACKIE FAIRLEY, CEO OF STARPHARMA : "VivaGel taking consideration of the various elements, such as funding and regulatory requirements to satisfy for a product such as this, we expect that the product would be available in its various forms probably within the next two to three years."

But I must admit Im out of my depth with regard to the technicalities of this!